Grifols (GIFLF) Current Taxes (2009 - 2025)
Grifols' (GIFLF) quarterly Current Taxes came in at $29.1 million in Q4 2025, down 55.36% on a YoY basis from $65.2 million in Q4 2024, and down 55.36% quarter-over-quarter from $65.2 million in Q4 2024.
Analysis
Grifols (GIFLF) Current Taxes (2009 - 2025) Analysis & Trends
Grifols (GIFLF) has reported Current Taxes for 17 consecutive years, with $29.1 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Current Taxes fell 55.36% year-over-year to $29.1 million; the trailing twelve-month figure through Dec 2025 stood at $29.1 million (down 55.36% YoY), and the FY2025 full-year result was $28.2 million, down 39.59% from the prior year.
- Current Taxes retreated to $29.1 million in Q4 2025 per GIFLF's latest filing, from $65.2 million in the prior quarter.
- Across five years, Current Taxes topped out at $65.2 million in Q4 2024 and bottomed at $5.2 million in Q4 2021.
- Historically, Current Taxes has averaged $26.2 million across 5 years, with a median of $16.0 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Current Taxes jumped 317.16% in 2024, then sank 55.36% in 2025.
- Over 5 years, Current Taxes stood at $5.2 million in 2021, then jumped by 209.8% to $16.0 million in 2022, then dropped by 2.37% to $15.6 million in 2023, then surged by 317.16% to $65.2 million in 2024, then tumbled by 55.36% to $29.1 million in 2025.
- According to Business Quant data, Current Taxes over the past three periods registered $29.1 million, $65.2 million, and $15.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 49.00 Mn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 86.90 Mn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | 74.18 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | 29.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 29.10 Mn |
| Dec 31, 2024 | 65.18 Mn |
| Dec 31, 2023 | 15.63 Mn |
| Dec 31, 2022 | 16.00 Mn |
| Dec 31, 2021 | 5.17 Mn |
| Dec 31, 2020 | 4.15 Mn |
| Dec 31, 2019 | 6.60 Mn |
| Dec 31, 2018 | 2.19 Mn |
| Jun 30, 2018 | 24.20 Mn |
| Dec 31, 2017 | 7.90 Mn |
| Jun 30, 2017 | 23.02 Mn |
| Dec 31, 2016 | 8.59 Mn |
| Sep 30, 2016 | 24.51 Mn |
| Jun 30, 2016 | 36.95 Mn |
| Dec 31, 2015 | 17.75 Mn |
| Sep 30, 2015 | 43.88 Mn |
| Jun 30, 2015 | 107,468.36 |
| Mar 31, 2015 | 113.58 Mn |
| Dec 31, 2014 | 109.31 Mn |
| Sep 30, 2014 | 78.87 Mn |